Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Mpox
Type of publications
Guidelines (2)
NITAG documentation (22)
SAGE documentation (7)
Systematic reviews (SYSVAC) (28)
Regions
Africa (1)
Americas (7)
Europe (12)
Western Pacific (3)
Diseases
Mpox (59)
Chikungunya (13)
Cholera (35)
COVID-19 (1599)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (20)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mumps (53)
Pertussis (122)
Pneumococcal disease (310)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
Moderate (1)
Low (7)
Critically low (6)
Not applicable (14)
59 results found
2022
∙
ATAGI
ATAGI clinical guidance on vaccination against Monkeypox
2022
∙
Conseil Supérieur de la Santé (CSS)
Belgium Vaccination strategy against Monkeypox (revision, August 2022)
2022
∙
NIAC
Recommendations for the use of Monkeypox Modified Vaccinia Ankara Vaccines, Imvanex or Jynneos, by the intradermal route
2022
∙
NACI, Public Health Agency of Canada
NACI Rapid Response - Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada
2022
∙
NIAC
NIAC Recommendations for Monkeypox Vaccination
2022
∙
Haute Autorité de Santé
the French public health agency on monkeypox vaccination
2022
∙
ACIP
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices
2022
Vaccination recommendations in response to the current monkeypox outbreak
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination strategy against Monkeypox
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
